These results, combined with our previous work (Hou et al., 2016), indicated that Tim-3 could inhibit the activity of both lymphocytes and macrophages and highlighted the value of anti-Tim-3 treatment in anti-malaria strategies. This evidence concerns the gene HAVCR2 and malaria.